The present study was aimed to evaluate the effects of Zingiber officinale on some biochemical parameters in type 2 diabetic (DM2) patients. In a randomized double-blind placebo controlled trial, 64 patients with DM2 were assigned to ginger or placebo groups (receiving 2 g/d of each). A 3 d diet record, anthropometric measurements and concentrations of fasting blood glucose (FPG), HbA1c, lipid profile (including total cholesterol, triglyceride, low density lipoprotein and high density lipoprotein) and also the homeostasis model assessment (HOMA) and quantitative insulin-sensitivity check index (QUICKI) were determined before and after 2 months of intervention. Ginger supplementation significantly lowered the levels of insulin (11.0 ± 2.3 versus 12.1 ± 3.3; p = 0.001), LDL-C (67.8 ± 27.2 versus 89.2 ± 24.9; p = 0.04), TG (127.7 ± 43.7 versus 128.2 ± 37.7; p = 0.03) and the HOMA index (3.9 ± 1.09 versus 4.5 ± 1.8; p = 0.002) and increased the QUICKI index (0.313 ± 0.012 versus 0.308 ± 0.012; p = 0.005) in comparison to the control group; while, there were no significant changes in FPG, TC, HDL-C and HbA1c (p > 0.05). In summary, ginger supplementation improved insulin sensitivity and some fractions of lipid profile in DM2 patients. Therefore it may be considered as a useful remedy to reduce the secondary complications of DM2.
The hypoglycemic, hypolipidemic and antioxidative effects of ginger in type 2 diabetic patients have been recently noticed. However given the very limited data on obesity, the present study was furthered to investigate those beneficial effects of ginger supplementation in obese women. Methods: In this clinical trial, 80 eligible obese women (aged 18-45 yr.) were randomly divided into two groups of ginger (receiving 2 g ginger powder as two 1g tablets per day) or placebo (corn starch to the same amount) for 12 weeks. Serum levels of glucose, lipid profile, malondialdehyde (MDA) and total antioxidant capacity (TAC) were determined before and after the intervention. Results: At the end of intervention, significant reductions of serum glucose, total cholesterol (TC), Triglyceride (TG), the TC/HDL.c and LDL.c/HDL.c ratios and increase of HDL.C were observed in both study groups. However, the decrease of serum TG was significantly (percent change: -20.51% vs. -4.92%; p=0.006) and the glucose reduction was non-significantly (percent change: -7.51% vs. -6.16%; p=0.669) more pronounced in the ginger group versus placebo. Moreover the concentration of MDA increased in ginger group (p=0.005) and TAC decreased in placebo group (p=0.029) as compared to the baseline without any significant difference between groups. Conclusion: Our findings revealed a minor beneficial effect of ginger powder supplementation on serum glucose and a moderate, significant effect on TG, as compared to the placebo. However ginger consumption did not cause any significant effect on serum MDA and TAC levels.